FDA Inspection 1279024 — Jinhai Zhu
The FDA completed an inspection of Jinhai Zhu on Jul 25, 2025 in Bengbu. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 25, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bengbu (China)
Additional Details
Clinical Investigator (CI)